Related Experiment Video

Updated: Jul 13, 2026

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
07:46

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000

Published on: October 15, 2010

Arterial compliance and endothelial function

Marcelo L G Correia1, William G Haynes

  • 1General Clinical Research Center (157 MRF), 200 Hawkins Drive, University of Iowa, Iowa City, IA 52242, USA. marcelo-correia@uiowa.edu

Current Diabetes Reports
|August 10, 2007
PubMed

Insights

Increased arterial stiffness, linked to cardiovascular events, may stem from endothelial dysfunction. Measuring arterial stiffness could identify high-risk individuals and guide therapies targeting endothelial mediators.

Area of Science:

  • Cardiovascular Medicine
  • Vascular Biology
  • Biomedical Engineering

Background:

  • Decreased arterial compliance (stiffness) is associated with cardiovascular events.
  • Endothelium-derived mediators influence vascular tone and structure, affecting arterial stiffness.
  • Endothelial dysfunction may contribute to atherosclerosis complications via increased arterial stiffness.

Purpose of the Study:

  • To explore the link between arterial stiffness and endothelial dysfunction.
  • To investigate the potential of therapeutic manipulation of endothelial mediators to reduce arterial stiffness.
  • To highlight the prognostic value of arterial stiffness measurements in identifying high-risk subjects.

Main Methods:

  • Utilizing techniques to measure arterial stiffness.
  • Assessing arterial stiffness as an index of endothelial dilator function.
  • Correlating arterial stiffness measures with cardiovascular events and endothelial function.

Main Results:

  • Increased arterial stiffness correlates with cardiovascular events.
  • Arterial stiffness may mediate the link between endothelial dysfunction and atherosclerosis complications.
  • Arterial stiffness measurements can serve as an index of endothelial dilator function.

Conclusions:

  • Arterial stiffness is a significant factor in cardiovascular risk.
  • Targeting endothelial mediators offers a potential therapeutic strategy for reducing arterial stiffness.
  • Arterial stiffness assessment provides valuable prognostic information for cardiovascular risk stratification.

More Related Videos

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test06:35

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test

Published on: April 27, 2016

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Autoregulation of Blood Flow01:17

Autoregulation of Blood Flow

Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.
Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...